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AbstrAct
Objective Pancreatic cancer has poor survival rates 
due to non-specific symptoms leading to later diagnosis. 
Understanding how patients interpret their symptoms 
could inform approaches to earlier diagnosis. This study 
sought to explore symptom appraisal and help-seeking 
among patients referred to secondary care for symptoms 
suggestive of pancreatic cancer.
Design Qualitative analysis of semistructured in-depth 
interviews. Data were analysed iteratively and thematically, 
informed by the Model of Pathways to Treatment.
Participants and setting Pancreatic cancer occurs rarely 
in younger adults, therefore patients aged ≥40 years 
were recruited from nine hospitals after being referred to 
hospital with symptoms suggestive of pancreatic cancer; 
all were participants in a cohort study. Interviews were 
conducted soon after referral, and where possible, before 
diagnosis.
results Twenty-six interviews were conducted (cancer 
n=13 (pancreas n=9, other intra-abdominal n=4), non-
cancer conditions n=13; age range 48–84 years; 14 
women). Time from first symptoms to first presentation 
to healthcare ranged from 1 day to 270 days, median 21 
days. We identified three main themes. Initial symptom 
appraisal usually began with intermittent, non-specific 
symptoms such as tiredness or appetite changes, 
attributed to diet and lifestyle, existing gastrointestinal 
conditions or side effects of medication. Responses to 
initial symptom appraisal included changes in meal type 
or frequency, or self-medication. Symptom changes 
such as alterations in appetite and enjoyment of food or 
weight loss usually prompted further appraisal. Triggers to 
seek help included a change or worsening of symptoms, 
particularly pain, which was often a ‘tipping point’. Help-
seeking was often encouraged by others. We found no 
differences in symptom appraisal and help-seeking 
between people diagnosed with cancer and those with 
other conditions.
conclusions Greater public and healthcare professional 
awareness of the combinations of subtle and intermittent 
symptoms, and their evolving nature, is needed to prompt 
timelier help-seeking and investigation among people with 
symptoms of pancreatic cancer.
IntrODuctIOn
Pancreatic cancer is the ninth most common 
cancer in the UK, with about 8000 cases diag-
nosed every year. Only 22% men and 20% 
women currently survive pancreatic cancer 
for 1 year or more, and it has the poorest 
5-year survival rates of all cancers at less than 
4%.1 This poor prognosis is mainly due to 
patients being diagnosed at a stage when 
curative treatment is not possible. Survival 
could be improved if patients could be diag-
nosed earlier.2 3
The key symptoms of pancreatic cancer 
have primarily been described from studies 
of patients after a diagnosis has been made. 
Prediagnosis case-control studies from the 
USA4 and UK5 6 confirm that these symptoms 
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Research
strengths and limitations of this study
 ► We believe this is the first study to compare the 
symptom appraisal and help-seeking experiences of 
patients referred to secondary care with symptoms 
suggestive of pancreatic cancer between people 
subsequently diagnosed with pancreatic cancer and 
people diagnosed with other non-cancer conditions. 
We were unable to identify any differences.
 ► The data collection and analysis of this study were 
guided by the model of pathways to treatment as 
recommended by the Aarhus statement to improve 
the design and reporting of studies on early cancer 
diagnosis.
 ► Risks of recall bias and post hoc rationalisation 
were reduced by recruiting at the time of referral to 
specialist care, and interviewing patients before or 
close to diagnosis.
 ► The subtlety of initial symptoms and their evolution 
over time is a novel finding, and provides some 
understanding of the complexities faced by patients 
when appraising their symptoms and seeking help 
in a timely way.
 ► Some of the most seriously ill patients were unable 
to be interviewed and their experiences may have 
differed from those in our sample.
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are also relevant for the community when making health-
care management decisions. While jaundice is the only 
symptom which is strongly predictive of pancreatic cancer, 
a number of non-specific symptoms such as nausea, 
vomiting, abdominal pain, back pain, constipation, diar-
rhoea, weight loss and malaise are also weakly associated.6 
The non-specific nature of these symptoms creates chal-
lenges for early recognition of a potentially serious condi-
tion by both patients and their General Practitioners (GP) 
. In a large English database study, over 40% of patients 
diagnosed with pancreatic cancer had visited their GP at 
least three times before referral to specialist care.7
There is limited evidence about the evolution of symp-
toms of pancreatic cancer over time, and how patients 
appraise their symptoms and decide to seek medical 
advice. One of the few studies to date interviewed patients 
or their relatives many months after diagnosis;8 such 
studies may be biased by post hoc rationalisation and 
recall bias. Furthermore, many symptoms of pancreatic 
cancer are also symptoms of other gastrointestinal or 
intra-abdominal cancers such as gall bladder, colon and 
ovarian cancer, which may be equally difficult to diagnose 
early.7
The aim of this study was therefore to use qualitative 
approaches to gain understanding of barriers and facil-
itators to symptom appraisal and help-seeking decisions 
among patients with symptoms suggestive of pancre-
atic cancer much earlier in their diagnostic pathway, 
to contribute to the development of interventions to 
promote earlier or more timely cancer diagnosis. Similar 
studies have been conducted for people with symptoms 
suggestive of lung and colorectal cancers.9–11 We recruited 
patients who were newly referred to hospital, thus 
providing the opportunity to investigate the complexities 
of patients’ symptom appraisal and decision-making, and 
explore pathways from their first symptom to first presen-
tation in primary care, emergency presentations and 
referrals to specialist services.
MethODs
Setting
This in-depth, face-to-face interview study was nested 
within the SYMPTOM Pancreas Study, a prospective 
cohort study investigating associations between symptoms 
and other factors on the total diagnostic interval and 
stage of diagnosis among patients with symptoms sugges-
tive of pancreatic cancer.12 The patients were recruited 
from nine hospitals in two regions of England (North-
East and Eastern). 
recruitment
Patients were recruited when referred to hospital via 
routine or urgent (2-week wait) routes to a gastroen-
terology or hepatopancreatobiliary clinic or relevant 
ultrasound department, or admitted via Accident and 
Emergency (A&E) or other specialists. Pancreatic cancer 
occurs rarely in younger adults, therefore patients were 
eligible if they were aged 40 years and over, and their GPs 
had reported symptoms suggestive of pancreatic cancer. 
They were initially sent an invitation letter and SYMPTOM 
Study questionnaire by post; people who completed the 
questionnaire were able to indicate whether they would 
be willing to take part in an interview. We purposively 
sampled patients (by region, age, gender, diagnosis) to 
obtain participants with a range of demographic and 
diagnosis characteristics.
Data collection
Interviews were undertaken between March 2012 and 
March 2014 by KM, LB and NH, all of who have exten-
sive qualitative research experience. They took place as 
soon as possible after referral to hospital. All diagnoses 
were confirmed from review of secondary care medical 
records.
Before starting the interview, the researcher explained 
the research process and written consent was obtained 
from the participant. The interview was semistructured, 
with the schedule (online supplementary file 1) devel-
oped from similar interviews undertaken with people 
recently diagnosed with cancer.13 By using open-ended 
questions we were able to explore the patients' appraisal 
of their symptoms and decisions to seek help. We encour-
aged the interviewees to share how they made sense of 
their symptoms and why they chose to seek help in the 
context of previous experiences and existing medical 
conditions. To assist in the clarification of the sequences 
of events and key dates along the pathway to diagnosis, 
we used a specifically designed calendar-landmarking 
instrument.14
The interviews lasted between 40min and 70 min and 
were conducted in participants’ homes. A relative, usually 
a spouse, was also present at several interviews at the 
participant’s request: they sometimes assisted in recall of 
events and confirmed participants’ accounts, but were 
not consented, and only the participant’s words were 
included as data in analyses. Interviews continued until 
no new themes were identified in three consecutive inter-
views and data saturation was reached.15 All interviews 
were audio-recorded, then professionally transcribed 
verbatim and anonymised via a confidential service.
Analyses
Theoretical model
Both data collection and analysis were underpinned by 
the theoretical approach of the Model of Pathways to 
Treatment16 17 as recommended by the Aarhus statement 
to improve the design and reporting of studies on early 
cancer diagnosis.18 The model considers the contribu-
tions of disease, patient and healthcare system factors 
to four intervals: appraisal, help-seeking, diagnostic and 
pretreatment. The first event is the detection of initial 
bodily changes, described as the ‘time point when a person 
becomes aware of body sensations or visual alterations, 
regardless of the meaning assigned to the change’, these 
then develop over time to ‘symptoms’, defined as a bodily 
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Table 1 Participant characteristics
Cancer 
diagnosis 
n=13 (%)
Other 
conditions 
diagnosis 
n=13 (%)
English region 9 (69)
  Eastern 10 (77)
  North-Eastern 3 (23) 4 (31)
Gender
  Female 6 (46) 8 (62)
  Male 7 (54) 5 (38)
Age
  Mean years (range) 67 (50–84) 63 (49–84)
  40–59 4 (31) 3 (23)
  60–69 4 (31) 4 (31)
  70–79 2 (15) 4 (31)
  80+ 3 (23) 2 (15)
Ethnicity
  White British 13 (100) 13 (100)
Educational qualifications
  Higher education 3 (23) 1 (8)
  Further education/secondary 
school
6 (46) 8 (62)
  None 4 (31) 4 (31)
Index of Multiple Deprivation 
(IMD) quintiles
  Least deprived 1 4 (31) 2 (15)
  2 4 (31) 4 (31)
  3 2 (15) 3 (23)
  4 3 (23) 2 (15)
  Most deprived 5 0 (0) 2 (15)
Diagnoses of cancer
  Pancreas 9 (69) –
  Duodenal 1 (8) –
  Gall bladder 1 (8) –
  Oesophageal 1 (8) –
  Lymphoma 1 (8) –
Other conditions
  Hiatus hernia – 3 (23)
  Gallstones – 2 (15)
  Pancreatitis – 2 (15)
  Others – 6 (46)
GP appointments made
  0* 0 (0) 2 (15)
  1 9 (62) 6 (46)
  2 1 (8) 4 (31)
  *Emergency presentation 3+ 3 (23) 1 (8)
change perceived to be abnormal. Symptom appraisal 
leads to perceiving a reason to seek help, and consulting 
with a healthcare professional. These key events repre-
sent the ‘time to presentation’ (TTP) period. We defined 
TTP as the interval between the patient-reported date of 
first noticing a symptom and their first consultation with 
a healthcare professional.
Analytical processes
The analytical process was iterative, starting after the first 
few interviews. Three researchers with social sciences 
expertise (KM, LB, NH) worked together on an initial 
thematic analysis with inductive coding,19 and then 
adopted a deductive approach guided by the frame-
work of the Model of Pathways to Treatment16 17 20 to 
construct themes and subthemes. These approaches were 
combined to ensure a rigorous and systematic progres-
sion through the five analytical steps: familiarisation with 
data; developing a thematic framework; indexing data to 
framework; mapping and questioning the data; and theo-
retical interpretation.21 The model was used at several 
points in the analysis process: first, to provide structure to 
understanding the patient pathways to diagnosis; second, 
to facilitate comparisons between participants diag-
nosed with cancer and those who presented with similar 
symptoms but were diagnosed with non-cancer condi-
tions. Finally, the researchers examined patient data 
by characteristics, including age, gender, comorbidity, 
geographical region and diagnosis, to seek patterns and 
non-confirming cases.
The study patient representatives (MJ, JL) have personal 
experiences of cancer, which was reflected in their inter-
pretation of the data. They contributed to all stages of 
analysis by reading transcripts and regular meetings with 
the research team, and the other authors (all with clinical 
or social science expertise) contributed to the interpreta-
tion of the data. Data management was assisted by NVivo 
V.9.
results
Sample (table 1)
Of the participants, 302/407 (74%) recruited into the 
main SYMPTOM Pancreas Study expressed an interest 
in an interview. Thirty-four individuals were recruited 
following purposive sampling, but 8 were not interviewed 
as they were too unwell to participate. Six were unaware 
of their diagnosis at interview.
Half (13/26) of the interviewees were ultimately diag-
nosed with cancer, 9 with pancreatic cancer (3 early 
stage, 3 late stage, 3 unstaged) and 4 with other cancers 
(duodenal, gall bladder, oesophageal, lymphoma). The 
13 participants with non-cancer diagnoses included hiatus 
hernia, gallstones and pancreatitis. All participants were 
interviewed soon after their referral to specialist care 
(range: 1 day to 18 weeks), with a quarter (6, 23%) prior 
to diagnosis, half (12, 46%) within 4 weeks of diagnosis, 
and the remainder within 18 weeks (8, 31%).
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Table 2 Illustrative quotations relating to symptom attribution, a subtheme of theme 1— initial appraisal of symptoms
Initial appraisal of symptoms
Diet and lifestyle ‘It comes and goes, it must be something that I eat and it just doesn’t agree with me’ (F, 60–69 years, 13–
26 weeks, non-cancer)
‘I think it’s the picking up, it’s the bending that does it a lot with my job as well, ‘cos I lift heavy (clothing) all 
day, and I’m putting them over people and then bending and sitting down’ (F, 40–59 years, regular attender 
to GP, cancer)
Existing 
gastrointestinal 
conditions
‘I’ve always suffered with what’s it called, you know, reflux, over the years, sometimes I could take some 
indigestion remedy and that Gaviscon thing and it’d calm down’ (F, 40–49 years, <2 weeks, non-cancer)
Other medical 
conditions, 
side effects of 
medication
‘At first I started putting it down to the diabetic pills, I thought ‘Well it’s probably because I’ve changed 
those’, you know, and this Pioglitazone, I kept thinking ‘Well it’s that’ (F 60–69 years, 2–4 weeks, cancer)
‘I’ve had this sort of tiredness and a little bit of discomfort on and off for a time, I thought it was possibly 
diabetes…it kept on… and we thought was perhaps as a result of some of the medication I was taking for 
other things.’ (M, 70–79 years, 13–26 weeks, cancer)
Duration of symptoms
Most participants were able to recall when they first 
noticed their symptom/s and the date they went to their 
GP, though for some it was difficult to recall the exact 
date they decided to seek help. The TTP ranged from 
1 day to 270 days, with a median of 21 days. Three indi-
viduals were frequent attenders to their GP and so we 
were unable to define the precise first date of presen-
tation. Two-thirds (68%) consulted their GP within 6 
weeks of their trigger symptom. While more than half 
(58%) consulted their GPs only once before referral 
to secondary care, four patients (16%) saw their GP on 
more than three occasions.
Qualitative themes
We were unable to find any clear differences regarding 
symptom appraisal or help-seeking between the accounts 
of people diagnosed with cancer and those with other 
conditions. We therefore report the findings together. We 
were also unable to find any clear differences according 
to whether or not participants knew their diagnosis at the 
time of the interview, or their characteristics including 
gender, age and region. Extracts from interviews illus-
trate the findings: each quotation is contextualised, by 
the patient’s gender (M/F), age (40–59 years, 60–69 
years, 70–79 years, 80+ years), TTP (weeks) and diagnosis 
(cancer, non-cancer).
Theme 1: initial appraisal of symptoms
Two main subthemes emerged as participants described 
how they first noticed and initially interpreted their symp-
toms, and often attributed them to a common non-se-
rious cause or condition.
Bodily changes
People mainly described initial subtle or non-specific 
bodily changes such as feeling tired or ‘different’. These 
changes were often intermittent and insidious in their 
development.
‘I’ve had this sort of tiredness and a little bit of discomfort 
on and off for a time’ (M, 70–79 years, 13–26 weeks, 
cancer)
‘I’ve felt a bit like as if I’ve got a nervous tummy, like it 
gurgles up…’ (F 50–59 years, regular attender to GP, 
non-cancer)
People also described subtle changes in appetite: 
‘Well I went off my food a bit I think, my daughter said I 
went off my food a bit’ (F, 80+ years, 2–4 weeks, cancer)
Symptom attributions (table 2)
Initial explanations for these bodily changes or symptoms 
mainly related to diet and other daily activities. Nine 
participants with other conditions, particularly gastro-
intestinal conditions such as gastro-oesophageal reflux 
disease, often appraised their new symptoms against their 
‘usual’ symptoms, and whether their treatment was still 
effective. This group tended to downplay their symptoms. 
Some people also attributed these bodily changes or symp-
toms to other medical conditions or side effects of their 
medication. Others ‘normalised’ their initial symptoms 
to being caused by ageing, common conditions such as 
a virus or common cold, indigestion or a urine infection.
These explanations were described in the rich context 
of people’s lives, such as being busy, caring for others or 
the time of the year. When considered in these contexts, 
most people initially felt that their symptoms were accept-
able and did not warrant seeking help:
‘I thought I was a bit tired-er than normal, but I mean, I was 
tearing around. My daughter was coming back for 3 months 
and they’ve got a house in the next village, I was over there 
doing things in the house, getting it ready.’ (F, 60–69 years, 
2–4 weeks, cancer)
Theme 2: responses to initial symptom appraisal
Participants reported a number of responses to initial 
symptom appraisal.
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Table 3 Illustrative quotations relating to symptom progression, a subtheme of theme 3—further appraisal of symptoms
Further appraisal of symptoms
Pain ‘Well, it varied, you know, sometimes I’d have the pain all day and that’s very wearing and painful…It’s just under 
the rib cage and it’s slightly to the right hand side, just slightly there, always in the same place.’ (F, 70–79 years, 
<2 weeks, non-cancer)
‘…I just had a nagging, more like a dull ache, underneath my bust and I thought it was indigestion and it didn’t 
seem to go away, it didn’t make any difference whether I ate or not, it was there quite a lot of the time’ (F, 70–79 
years, 2–4 weeks, cancer)
‘After Christmas that then became all day, every day. I was going to bed with a stomach ache and I was waking 
up with a stomach ache…It was there all the while and you know, it didn’t make sense that I’d have a problem 
all the while so I thought I was imagining it’ (M, 60–69 years, 2–4 weeks, cancer)
Progressive 
changes in 
appetite and 
enjoyment of 
food
‘I was actually going off the actual taste of food, I wasn’t enjoying food anymore, things that I would normally eat 
I wasn’t enjoying’ (M, 60–69 years, 5–8 weeks, cancer)
‘Well it became quite traumatic at one point, when I just (did) not want an evening meal at all. I always eat a 
reasonable breakfast, but for the evening meal I had no appetite’ (M, 80+ years, <2 weeks, cancer)
…and I was eating less and smaller meals and being really careful what I ate, and I thought ‘it’s good for you but 
you shouldn’t have to be that precise when you eat’ (F, 60–69 years, 26–52 weeks, non-cancer)
Weight loss ‘I was also suffering uncomfortable, you know, let’s say stomach irritation, indigestion, wasn’t happy eating, so 
I literally went along to say ‘look, this isn’t right, I don’t mind losing weight but not like this’' (M 60–69 years, 
5–8 weeks, cancer)
‘I’d probably lost about four pounds which was concerning me but then I thought, you’ve reduced the amount 
that you’re eating…’ (F 50–59 years, 2–4 weeks, non-cancer)
Lifestyle adaptations
In the light of these attributions and explanations, some 
people began to make adaptations to their diet or daily 
living activities to alleviate their symptoms; in some cases, 
these changes were quite significant:
‘If I had smaller meals, but slightly more frequently, I could 
actually control keeping food, you know, keeping comfortable’ 
(M, 60–69 years, 5–8 weeks, cancer)
‘I think you learn to live with it and you just adapt to it 
and start to make the changes so it doesn’t happen… I think 
what had happened with me is I couldn’t control it any 
longer, no matter if I stopped eating things, didn’t eat out, 
it was happening anyway’ (F, 60–69 years, 26–52 weeks, 
non-cancer)
Role of others in appraisal and adaptations
Some people discussed their early symptoms with close 
relatives, particularly partners or children. This could 
prompt discussions around potential explanations and 
suggestions for improving symptoms, such as changes in 
content or timing of meals; at times it could also lead to 
delays in help-seeking:
‘When I mentioned to my wife the colour of my stools, which 
was the first symptom, she said I wasn’t getting enough 
carbohydrates or protein or something…something wasn’t 
right in my diet. So I changed my diet, I was eating fruit 
and vegetables and things like that, a lot more, and it still 
stayed the same.’ (M, 50–59 years, 13–26 weeks, cancer)
Theme 3: further appraisal of symptoms
Changes in patterns of symptoms often led participants to 
further appraise their symptoms, and to question the reasons 
for their occurrence and their original explanations.
Symptom progression (table 3)
Symptoms became of greater concern when they became 
more severe or frequent, or when further subtle symp-
toms developed. In some cases, it appeared that there 
was progression from subtle and intermittent symptoms 
of a manageable and tolerable nature, to symptoms 
which were more alarming such as pain. Across the whole 
sample, people described pain in a number of different 
parts of the body including their shoulder, chest, upper 
abdomen and back.
Another man described the chronology of his symp-
toms; having started with mild indigestion symptoms, 
additional, more alarming, symptoms developed:
‘gradually… the stools over a period of time, but the urine it 
seemed to happen more or less in a week, from normal colour 
to really deep colour’ (M, 50–59 years, 13–26 weeks, 
cancer)
Many participants reported subtle yet progressive 
changes to their appetite and enjoyment of food. Weight 
loss as a result of changes in appetite was also reported by 
a few participants.
Symptom monitoring and self-management
The subtlety and slow progression of symptoms prompted 
some participants to monitor their symptoms, and some 
to consider alternative self-management strategies. Many 
used over-the-counter remedies to attempt to alleviate 
their symptoms of indigestion or abdominal pain:
‘It was only when I started feeling a bit of strangeness that I 
decided to try and keep a pattern of them’ (F, 60–69 years, 
2–4 weeks, cancer)
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Table 4 Illustrative quotations relating to theme 4: deciding to seek help
Illustrative quotations
Pain on a 
background 
of more subtle 
symptoms
‘Sometimes I could take some indigestion remedy and… it’d calm down, but this were a different kind of pain, 
this were, oh it’s excruciating pain…but that were the first time that… I thought there’s something not right 
here and I need to get some help.’ (F, 40–49 years, <2 weeks, non-cancer)
Help-seeking 
encouraged by 
others
‘The kids had been saying ‘mum you’re always ill’ and I thought ‘oh yeah, I am’. Because you, I think you sort 
of drift, you get used to things and you don’t see any problem with it, and when other people start to say, you 
know ‘hang on’ and then I thought ‘oh yeah’'(F, 60–69 years, 26–52 weeks, non-cancer)
‘I’d fall asleep on my desk, you know, this isn’t me, and other people said ‘oh you’re losing weight’… people 
actually were saying ‘you don’t look well’. It’s another lever to go and see, to get it sorted’ (M, 60–69 years, 
5–8 weeks, cancer)
Legitimate 
reason 
‘I think my basic problem was pain… from arthritis that I’d had for some time, but it was proving impossible to 
control it by the methods I was using’(M 80-89, 2-4 weeks, cancer)
Impact on life
Most people described how their symptoms gradually or 
rapidly impacted on their quality of life and daily routine, 
including their social activities and hobbies, as well as 
their ability to sleep. Some felt that they were less able to 
complete tasks at home; for others, work became more 
challenging:
‘I decided I’d got this burning pain and I noticed that I 
was beginning to get a little bit short of breath, and also I 
couldn’t do the same things I used to, like I found digging 
was becoming impossible’ (M, 70–79 years, 13–26 weeks, 
non-cancer)
Previous family and personal history of cancer
A few people expressed a concern that they might 
develop cancer because they had lost a close relative to 
the disease; one had also previously suffered from cancer. 
These people were concerned about their personal risk of 
cancer and reported that they often considered whether 
their symptoms matched those which they expected from 
having cancer. Conversely one woman, subsequently diag-
nosed with a benign condition, had not considered cancer 
as a possibility because her symptoms did not match her 
expectations of cancer:
‘I knew I’m generally healthy, I mean I’ve been going 
swimming and to the gym…it wasn’t seriously debilitating…I 
expect when you have cancer that you have more symptoms’ 
(F, 60–69 years, 26–52 weeks, non-cancer)
Theme 4: deciding to seek help (table 4)
The further appraisal of symptoms eventually led most 
participants to decide to seek help from primary care, 
although several had emergency visits to A&E.
Triggers
Triggers to seek help usually involved an increased 
frequency or intensity of symptoms, although sometimes 
it was precipitated by an alarming event, usually pain. 
Pain was often the ‘tipping point’ to seek help against a 
background of other more subtle symptoms. For those 
without pain, triggers were often complex, and could 
involve interpreting new or changing symptoms along-
side symptoms from other existing conditions and, in 
some instances, symptoms from other acute illnesses. 
Healthcare factors, such as availability of a GP appoint-
ment, were seldom mentioned.
Legitimising help-seeking
People were often encouraged to seek help by their 
spouse, family members and friends; they were particularly 
influenced by comments about changes in their general 
well-being, or recall of specific symptom episodes. A few 
participants reported considering whether their symp-
toms had become a ‘legitimate’ reason to seek healthcare 
when self-management strategies became ineffective; they 
tended to refer to the length of time symptoms had been 
experienced, and their reduced ability to cope.
DIscussIOn
This is the first study to investigate symptom appraisal and 
help-seeking in patients newly referred to hospital with 
symptoms suggestive of pancreatic cancer. Due to their 
subtle and intermittent pattern, many people initially just 
monitored their symptoms. Symptoms were interpreted 
based on previous experiences with common conditions 
such as gastroenteritis, or impact of dietary change or 
existing gastrointestinal conditions. Many made changes 
to their eating patterns including type of food, and 
frequency and quantity of meals, or managed their symp-
toms with over-the-counter medication. Consequently, 
they tended not to go to their GP at that point. Changes 
to symptom frequency, duration or severity, their impact 
on daily life, or the appearance of additional symptoms, 
particularly pain, led many people to further appraise 
their symptoms and visit their GP. Family and friends 
often made important contributions to encouraging help-
seeking by reflecting on changes in symptoms, although 
at times social contacts could reinforce self-management 
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strategies. These patterns of symptom appraisal and help-
seeking were seen regardless of final diagnosis.
strengths and limitations
The major strength of this study is that we prospectively 
recruited patients with symptoms suggestive of pancre-
atic cancer, and interviewed them during their pathway 
to diagnosis and treatment. This allowed detailed discus-
sions about factors affecting symptom appraisal and help-
seeking while they were still fresh events, and greatly 
reduced the possibility of post hoc rationalisation and 
recall bias. We have used similar approaches in inter-
view studies with people recently diagnosed with mela-
noma,22 and people with symptoms suggestive of lung10 
and colorectal12 cancers. Recruiting patients during their 
diagnostic pathway enabled comparisons about symptom 
appraisal and help-seeking between people subsequently 
diagnosed with cancer and people with non-cancer 
conditions; importantly, we were not able to find differ-
ences between them. Our recruitment process meant 
that some patients were subsequently diagnosed with a 
cancer other than pancreatic cancer. We do not consider 
this a weakness of the study; rather, it serves to highlight 
the complexity and challenges of diagnosing pancreatic 
cancer, and how similarly a range of upper gastrointes-
tinal cancers can present. While we aimed to recruit equal 
numbers of patients with pancreatic cancer and benign 
conditions, several patients with cancer withdrew before 
interview as they were too unwell.
Our approach to data collection and analysis was 
strengthened by the use of a strong theoretical frame-
work: underpinned by recommendations from the Aarhus 
statement on improving design and reporting studies on 
early cancer diagnosis,18 we applied the framework of the 
widely used Model of Pathways to Treatment,16 17 and a 
specifically developed calendar-landmarking instrument 
which aided some participants’ recall of dates of their 
symptoms and help-seeking.14 Other strengths include 
recruitment from two English regions and a number of 
hospitals to ensure patients from a wide range of socio-
economic backgrounds, and who had entered hospital 
care via a variety of routes, enabling us to gather a broad 
range of experiences. Finally, the research team had a 
broad range of scientific and clinical expertise, and we 
sought inputs from our lay members at all stages of the 
research process, including analysis and interpretation of 
the data.
While we acknowledge that these experiences may not 
be representative of all people with symptoms suggestive 
of pancreatic cancer, the demographics of this cohort are 
similar to that of the main SYMPTOM Pancreas Study.12 
Although a major finding was that there were similar 
patterns in symptom appraisal and help-seeking between 
those diagnosed with cancer and those with other diag-
noses, this may have been partly due to recruiting patients 
relatively late in their diagnostic pathway, when GPs had 
referred with a suspicion of pancreatic cancer. Ideally we 
would have recruited people with similar symptoms from 
earlier in their diagnostic pathway and from primary 
care, but there are significant challenges with the feasi-
bility and costs of recruiting such a cohort containing 
sufficient cases of pancreatic cancer. The presence of 
relatives in some interviews may have led to potential bias 
in the participants’ accounts and recollections, but this 
was minimised by only including participants’ words in 
the analysis. Finally, we can only report the experiences 
shared with the researchers at the time of the interview: 
there may have been events which were not discussed if 
they were felt to be too emotional or private.
comparison with existing literature
Although these findings are in line with the broader 
literature investigating help-seeking for cancer symp-
toms,10 12 22 very little has been published on symptom 
appraisal and help-seeking among patients diagnosed 
with pancreatic cancer. Evans et al recently reported the 
only other similar study, also set in England, and high-
lighted the intermittent and subtle nature of symptoms 
with their title: ‘'It can't be very important because it 
comes and goes’- patients' accounts of intermittent symp-
toms preceding a pancreatic cancer diagnosis’.8 However, 
their interviews were conducted with people up to several 
years after a diagnosis of pancreatic cancer, and included 
data from interviews with relatives of people who had died. 
Our findings are strengthened by interviewing patients 
earlier in their illness pathway, thereby capturing subtle 
assessments of initial bodily changes and explanations, 
and minimising post hoc rationalisation and recall bias. 
We could not identify any subtle differences in the nature 
of symptoms or help-seeking between those who eventu-
ally were found to have pancreatic cancer, and those who 
were not. This is consistent with the quantitative findings 
of the SYMPTOM Pancreas Study,9 where the evolution 
of additional symptoms such as fatigue, change in bowel 
habit, weight loss, decreased appetite and jaundice were 
associated with pancreatic cancer.
Other studies of pancreatic cancer symptoms have 
mainly used quantitative retrospective designs. For 
example, Stapley et al undertook a case-control study 
using routinely recorded UK primary care data which 
demonstrated how poorly predictive most symptoms are 
of pancreatic cancer in primary care populations. While 
the positive predictive value of jaundice was relatively high 
(21%), it was much lower for other symptoms including 
abdominal and back pain, nausea, vomiting, change in 
bowel habit, weight loss and malaise (<1%).6 Keane et al 
more recently used another large UK primary care data-
base to investigate the early symptom profiles of patients 
diagnosed with pancreatic ductal or biliary adenocarci-
noma and found a similar wide range of early symptoms.23 
They also found that, in the year prior to diagnosis, these 
patients visited their GP on a median of 18 (IQR 11–27) 
occasions, which resonated with findings from another 
large English database study showing that 41% of patients 
diagnosed with pancreatic cancer had visited their GP 
at least three times before referral to specialist care.7 In 
8 Mills K, et al. BMJ Open 2017;7:e015682. doi:10.1136/bmjopen-2016-015682
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contrast, more than half our sample reported only visiting 
their GP once before referral, suggesting either that our 
sample were recruited early in their symptom pathway, or 
perhaps that they had symptoms such as jaundice which 
are more likely to prompt early referral. Other quanti-
tative studies set among patients newly diagnosed with 
pancreatic cancer have reported fatigue, dyspepsia and 
subtle changes in appetite such as early satiety in the 
preceding 6 months, confirming our finding that there 
may be a window of opportunity for timely investigations 
when patients report combinations of non-specific or 
subtle symptoms.4 24 25
Implications for research and practice
Our findings add to current knowledge about the subtle 
and non-specific nature of early symptoms of pancreatic 
cancer, and enhance our understanding of their often 
intermittent and insidious nature. They highlight the 
importance of ongoing, and often iterative, appraisal 
of symptoms as described in the Model of Pathways to 
Treatment.16 17 The findings have characterised pain 
as a ‘tipping point’ for presentation to healthcare, and 
underpinned the importance of family and friends in 
symptom monitoring, recognising evolving and new 
symptoms and endorsement of help-seeking.26 The chal-
lenge for symptom awareness campaigns is to promote 
earlier presentation with these more subtle and intermit-
tent symptoms which lead to changes in eating patterns 
including type of food, and frequency and quantity of 
meals, and weight loss. The ‘Know 4 Sure’ campaign 
was one of the first to raise awareness of non-site-spe-
cific symptoms including weight loss, pain, lump and 
unexplained bleeding. It was associated with increase in 
referrals for a range of cancers including upper gastroin-
testinal (GI) cancer.27 Whether public health campaigns 
can effectively promote messages about combinations of 
non-specific symptoms is unknown, but may be important 
in pancreatic cancer.
The newly revised National Institute for Health and 
Care Excellence guidance on Suspected Cancer: Recog-
nition and Referral28 supports a lower threshold for inves-
tigating and referring people with single and multiple 
symptoms suggestive of pancreatic cancer, particularly 
those in higher-risk groups such as patients with newly 
diagnosed diabetes. The findings from this study could 
inform GP education approaches to promote timely inves-
tigation and referral for people with these non-specific 
and intermittent symptoms. These numerous subtle and 
non-specific symptoms, when combined with abnormal 
blood tests and the use of clinical decision support tools, 
might alert GPs to a possible pancreatic cancer diagnosis 
earlier. Safety-netting, defined as is a diagnostic strategy 
or consultation technique to help manage diagnostic 
uncertainty and ensure that patients are followed up in a 
timely and appropriate manner, is also important due to 
the evolving nature of symptoms; appropriate strategies 
would include symptom monitoring and early review.
In conclusion, this study has described and contex-
tualised the appraisal and help-seeking behaviours of 
patients with symptoms that could represent pancreatic 
cancer. Greater awareness of combinations of the subtle 
and intermittent symptoms, and their evolving nature, is 
needed to prompt timelier help-seeking and investigation 
among people with symptoms of pancreatic cancer.
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